Drug
Venadaparib clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
- IDX-1197
- 1
Studies by the year they started
4 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Idience Co., Ltd. (4)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses venadaparib is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric CancerActive, not recruitingPhase 1/2Idience Co., Ltd.NCT04725994Written as IDX-1197+XELOX
- Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid TumorsCompletedPhase 1Idience Co., Ltd.NCT03317743Written as NOV140101 (IDX-1197)
- Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)CompletedPhase 1/2Idience Co., Ltd.NCT04174716Written as IDX-1197
- Food Effect Study of IDX-1197 in Healthy SubjectsCompletedPhase 1Idience Co., Ltd.NCT05202912Written as IDX-1197(After a meal)
Codes
What other systems call venadaparib · ClinicalTrials.gg INT017615
- UNII (FDA) PUP792O0IWVENADAPARIBOne source FDA
- NCI Thesaurus C175871VenadaparibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | PUP792O0IW | VENADAPARIB | One source FDA |
| NCI Thesaurus | C175871 | Venadaparib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.